Scientech Research LLC’s IO Biotech IOBT Stock Holding History

Scientech Research LLC’s Portfolio IOBT Stock Details IOBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,255	Closed	-$6.85K	–	604
2025 Q4	$6.85K	Buy	+11,255	New	+$8.36K	﹤0.01%	475

Other funds holding IOBT

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return

Scientech Research LLC's IOBT Position: Q1 2026 in Review

Scientech Research LLC sold out of IO Biotech (IOBT) in Q1 2026, closing a stake of 11,255 shares — an estimated $6.85K sold.

Scientech Research LLC first reported a position in IOBT in Q4 2025 and held it in 1 quarter. The position peaked at $6.85K in Q4 2025. 12 funds tracked by Wall St. Rank hold IOBT as of Q1 2026.

Scientech Research LLC reported no remaining IO Biotech position as of Q1 2026 after selling out during the quarter.
Scientech Research LLC sold 11,255 IO Biotech shares in Q1 2026, an estimated $6.85K.
Scientech Research LLC first reported a position in IO Biotech in Q4 2025 and held it in 1 quarter.
Scientech Research LLC's IO Biotech position peaked at $6.85K in Q4 2025.
12 funds tracked by Wall St. Rank held IO Biotech as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.